SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries
6 references·0 citing·28 second hop
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries (2021)Similarities and Differences in Health Te…Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Using health technology asses…Variation in Health Technology Assessment and Reimbursement Processes in Europe (2016)Variation in Health Technolog…European network for health technology assessment – EUnetHTA (2013)European network for health t…Health Technology Assessment: Lessons Learned from Around the World—An Overview (2009)Health Technology Assessment:…Ensuring value for money in health care: the role of health technology assessment in the European Union (2008)Ensuring value for money in h…The development of health technology assessment (2003)The development of health tec…Effectiveness and Efficiency (1994)Cochrane Collaboration Handbook (1996)Patient-based health technology assessment: A vision of the future (2007)The New Industrial State (2007)The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization (2015)Medical Care Costs: How Much Welfare Loss? (1992)Is Technological Change In Medicine Worth It? (2001)National Institute for Clinical Excellence and its value judgments (2004)Medical technology procurement in Europe: A cross-country comparison of current practice and policy (2010)Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions (2012)Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art (2019)Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT (2004)Technology Assessment (2005)Retaining, and Enhancing, the QALY (2009)Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review (2015)Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why? (2016)A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2015)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework (2017)Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward (2019)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Accelerated Access to Innovative Medicines for Patients in Need (2014)Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries (2015)The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment Framework (2021)Comparing access to orphan medicinal products in Europe (2019)Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations (2020)
this work references cited by second hop

References

  • 2003The development of health technology assessment334 cited
  • 2017Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries306 cited
  • 2013European network for health technology assessment – EUnetHTA148 cited
  • 2016Variation in Health Technology Assessment and Reimbursement Processes in Europe122 cited
  • 2008Ensuring value for money in health care: the role of health technology assessment in the European Union120 cited
  • 2009Health Technology Assessment: Lessons Learned from Around the World—An Overview116 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work